| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diarrhea | D003967 | 32 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Fractures, Spontaneous | D005598 | 4 associated lipids |
| Osteomyelitis | D010019 | 10 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Intraoperative Complications | D007431 | 5 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
| Hyperbilirubinemia | D006932 | 11 associated lipids |
| Anaphylaxis | D000707 | 35 associated lipids |
Rifamycin SV
Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.
Cross Reference
Introduction
To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Rifamycin SV?
Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Rifamycin SV
PubChem Associated disorders and diseases
What pathways are associated with Rifamycin SV
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Rifamycin SV?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Rifamycin SV?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
What genes are associated with Rifamycin SV?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Rifamycin SV
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Pyta K et al. | Regioselective long-range proton transfer in new rifamycin antibiotics: a process in which crown ethers act as stronger Brønsted bases than amines. | 2015 | Chemphyschem | pmid:25639734 |
| Setti G et al. | The treatment of idiopathic and secondary hydrarthrosis of the knee by intra-articular Rifamycin SV. | 1990 Oct-Dec | Chir Organi Mov | pmid:2098221 |
| Nettles RE et al. | Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use. | 2004 | Clin. Infect. Dis. | pmid:14986259 |
| Gentile S et al. | The implication of bilitranslocase function in the impaired rifamycin SV metabolism in Gilbert's syndrome. | 1985 | Clin. Sci. | pmid:2485269 |
| Mancuso G and Masarà N | Contact urticaria and severe anaphylaxis from rifamycin SV. | 1992 | Contact Derm. | pmid:1395622 |
| Testa A et al. | Preclinical Evaluation of [F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters. | 2018 | Contrast Media Mol Imaging | pmid:30154685 |
| Wang W et al. | A novel two-component system amrB-amkB involved in the regulation of central carbohydrate metabolism in rifamycin SV-producing Amycolatopsis mediterranei U32. | 2004 | Curr. Microbiol. | pmid:15018097 |
| Chen C et al. | Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1. | 2005 | Drug Metab. Dispos. | pmid:15616150 |
| Mita S et al. | Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs. | 2006 | Drug Metab. Dispos. | pmid:16760228 |
| Garver E et al. | Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat. | 2008 | Drug Metab. Dispos. | pmid:18755851 |
| Zhang W et al. | A novel transmembrane serine/threonine protein kinase gene from a rifamycin SV-producing amycolatopsis mediterranei U32. | 2000 | Eur. J. Biochem. | pmid:10848993 |
| Persico M et al. | The association between rifamycin-SV (R-SV) related hyperbilirubinaemia and antipyrine clearance as a new test of liver function in cirrhosis. | 1994 | Eur. J. Clin. Invest. | pmid:8033955 |
| Renoult E et al. | Effect of topical rifamycin SV treatment on cyclosporin A blood levels in a renal transplant recipient. | 1991 | Eur. J. Clin. Pharmacol. | pmid:2050183 |
| Lin SW et al. | Rifamycin SV MMX for the treatment of traveler's diarrhea. | 2017 | Expert Opin Pharmacother | pmid:28697313 |
| Quinn FR | The quantitative structure-activity relationship of rifamycin B amide and hydrazide toxicity in mice. | 1982 | Farmaco Sci | pmid:7056391 |
| Nikiforov VG et al. | A derivative of rifamycin SV inhibiting rifampicin-resistant RNA polymerase of Escherichia coli. | 1982 | FEBS Lett. | pmid:6761147 |
| Muñiz P et al. | The role of 8-hydroxy-2'-deoxyguanosine in rifamycin-induced DNA damage. | 1995 | Free Radic. Biol. Med. | pmid:7750799 |
| Michelson AM | Pro-oxidant action of superoxide dismutase in the autoxidation of rifamycin SV. | 1986 | Free Radic. Res. Commun. | pmid:2577735 |
| Sáez GT et al. | The role of glutathione in protection against DNA damage induced by rifamycin SV and copper(II) ions. | 1993 | Free Radic. Res. Commun. | pmid:8225041 |
| Fernandes D and Giacinti F | [Agranulocytosis induced by rifamycin SV in a patient with Hodgkin's disease. Immunologic considerations and pathogenetic interpretations]. | 1982 Jan-Jun | G Batteriol Virol Immunol | pmid:7187341 |